|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 588.05 USD | -3.01% |
|
-3.74% | +4.70% |
| Capitalization | 17.08B 14.52B 13.46B 12.58B 23.45B 1,569B 24.86B 154B 61.08B 741B 64.04B 62.73B 2,695B | P/E ratio 2025 * |
41x | P/E ratio 2026 * | 36.8x |
|---|---|---|---|---|---|
| Enterprise value | 16.67B 14.18B 13.14B 12.28B 22.9B 1,532B 24.27B 150B 59.64B 723B 62.52B 61.24B 2,631B | EV / Sales 2025 * |
6.64x | EV / Sales 2026 * | 5.69x |
| Free-Float |
83.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | -3.01% | ||
| 1 week | -3.74% | ||
| Current month | +4.70% | ||
| 1 month | +3.22% | ||
| 3 months | -1.43% | ||
| 6 months | +34.44% | ||
| Current year | +4.70% |
| 1 week | 579.03 | 624 | |
| 1 month | 551 | 628.92 | |
| Current year | 551 | 628.92 | |
| 1 year | 250.05 | 628.92 | |
| 3 years | 167 | 628.92 | |
| 5 years | 126.94 | 628.92 | |
| 10 years | 21.76 | 628.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 69 | 1992-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 51 | 2021-07-31 |
Jesse Geiger
PSD | President | 51 | 2021-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 69 | 1992-06-30 |
Robert Kraft
BRD | Director/Board Member | 55 | 2016-06-30 |
Brian Carley
BRD | Director/Board Member | 72 | 2016-06-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.01% | -3.74% | +69.03% | +145.51% | 17.08B | ||
| +0.04% | -1.56% | -4.31% | +14.75% | 49.33B | ||
| -1.56% | -1.00% | +14.23% | +2.87% | 40.71B | ||
| +0.15% | +0.33% | +52.68% | +26.14% | 37.49B | ||
| +1.92% | +0.71% | +22.15% | +42.46% | 31.07B | ||
| -0.99% | -2.20% | +185.93% | +328.06% | 22.97B | ||
| -0.90% | -2.40% | +46.36% | +10.78% | 14.81B | ||
| Average | -0.98% | -0.96% | +55.15% | +81.51% | 30.49B | |
| Weighted average by Cap. | -0.98% | -0.78% | +42.94% | +62.42% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.51B 2.14B 1.98B 1.85B 3.45B 231B 3.66B 22.62B 8.98B 109B 9.42B 9.22B 396B | 2.81B 2.39B 2.22B 2.07B 3.86B 258B 4.09B 25.35B 10.06B 122B 10.55B 10.33B 444B |
| Net income | 436M 371M 344M 321M 599M 40.07B 635M 3.93B 1.56B 18.92B 1.64B 1.6B 68.82B | 479M 408M 378M 353M 658M 44.05B 698M 4.32B 1.71B 20.8B 1.8B 1.76B 75.66B |
| Net Debt | -404M -344M -319M -298M -555M -37.13B -588M -3.64B -1.45B -17.53B -1.52B -1.48B -63.77B | -1.06B -902M -836M -781M -1.46B -97.46B -1.54B -9.56B -3.79B -46.02B -3.98B -3.9B -167B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-23 | 588.05 $ | -3.01% | 301,634 |
| 26-01-22 | 606.27 $ | -2.31% | 182,885 |
| 26-01-21 | 620.59 $ | +3.02% | 251,248 |
| 26-01-20 | 602.40 $ | -1.39% | 207,156 |
| 26-01-16 | 610.90 $ | -1.16% | 232,679 |
Delayed Quote Nasdaq, January 23, 2026 at 04:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MEDP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















